On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
Dadra's specialization lies in the production of oral solid dosage forms and the manufacture of the blockbuster drug Revlimid, a vital revenue driver for Sun ... Advisory Alert: It has come ...
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign ...
Stagnant liquid inside an air purification unit, hundreds of complaints on tablet counts and inadequate guidance to call centers are but a few of the litany of issues outlined in the FDA’s Form 483 ...
The FDA will close out April with five target action dates around indications that include pediatric seizures and a ...
In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies based on advanced cannabinoids science, to treat various conditions to improve patients ...
Medtech startup EzeRx Health Tech Pvt Ltd, which counts drugmaker Sun Pharma as its largest investor, is in talks with at least two venture capital firms and a state-run company to raise fresh equity ...
With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of its prolonged CBD release ...
Now read: CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval ...
BRAF gene fusions are much more prevalent than BRAF V600 mutations, Day One’s head of R&D, Samuel Blackman, M.D., Ph.D., told Fierce Pharma in an interview ahead of the FDA approval. Samuel ...